Ranking · Winter 2022 · Healthcare · Drug Discovery and Delivery

Rosebud Biosciences

Growing micro-organs to find new drugs

6.2%

odds of being acquired in the next two years

0.9× the average (6.8%)

#2473 of 4,339 active YC companies · top 58%

Team of 3 · San Francisco, CA, USA; San Carlos, CA, USA

Raises the odds

↑ team of 3–5

↑ based in United States of America

↑ based in America / Canada

↑ changed its name (pivot)

Lowers the odds

↓ industry: Healthcare

↓ tag: Biotech

↓ sector: Drug Discovery and Delivery

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Rosebud Biosciences's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

rosebudbiosciences.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub